Natural Capsules Profit & Loss Annual

BSE: 524654 | NSE: NATCAPSUQ | ISIN: INE936B01015 | Sector: Biotechnology & Drugs

148.00 -2.25 (-1.50%)Updated : 17 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	207.60	160.92	145.30	144.54
Other Net	-0.19	-1.27	0.23	-0.10
Diluted Weighted Average Shares	1.04	1.03	0.93	0.93
Depreciation/ Amortization	17.14	9.12	8.67	7.21
Operating Income	-20.39	8.28	10.12	27.83
Net Income	-17.07	0.62	5.55	18.45
Income Availableto Com Excl Extra Ord	-17.07	0.62	5.55	18.45
Other Operating Expenses Total	0.50	0.54	0.49	0.15
Net Income Before Taxes	-27.92	2.79	8.05	24.99
Minority Interest	7.59	-	-	-
Net Income After Taxes	-24.66	0.62	5.55	18.45
Income Availableto Com Incl Extra Ord	-17.07	0.62	5.55	18.45
Costof Revenue Total	139.00	110.92	103.30	100.81
Gross Profit	48.21	58.28	52.12	71.57
Interest Inc( Exp) Net- Non- Op Total	-7.33	-4.22	-2.30	-2.79
Unusual Expense( Income)	0.00	0.00	-	0.00
Diluted Net Income	-17.07	0.62	5.55	18.45
Provisionfor Income Taxes	-3.26	2.17	2.50	6.55
period Type	-	-	-	-
Net Income Before Extra Items	-17.07	0.62	5.55	18.45
Total Revenue	187.20	169.21	155.42	172.37
period Length	12.00	12.00	12.00	12.00
Revenue	187.20	169.21	155.42	172.37
Selling/ General/ Admin Expenses Total	47.39	38.74	30.76	33.99
Diluted Normalized EPS	-16.44	0.60	5.95	19.85
Research Development	3.57	1.60	2.08	2.39
Diluted EPS Excluding Extra Ord Items	-16.44	0.60	5.95	19.89
DPS- Common Stock Primary Issue	-	-	0.00	1.00
Gain( Loss)on Saleof Assets	-	-	-	0.05